Founded with a mission to revolutionize reproductive and urogenital health, Luca Biologics is a biotechnology company focused on developing living medicines that target the vaginal microbiome. The company's vision is to harness the power of microbiome science to create innovative treatments that improve human health. Their primary products and services revolve around pioneering microbiome-based therapies designed to address various conditions affecting the reproductive and urogenital systems.
Notable figures affiliated with Luca Biologics include Dr. Alessio Fasano, a prominent member of the Seed Health Scientific Board. The company has achieved significant milestones in advancing microbiome science, contributing to a new understanding of disease treatment and prevention. Luca Biologics' work has had a substantial impact on the biotechnology sector, positioning them at the forefront of a scientific revolution in microbiome research.
